Literature DB >> 6252810

Primary hepatocellular carcinoma in the Asian Pacific region.

C J Oon, K Okuda, R Pang.   

Abstract

This survey was conducted to obtain current data relating to the epidemiology, aetiological factors, diagnostic tests in use, effect of various treatments and the evaluation of the extent of any population screening procedures. From replies to questionnaires sent to countries in West, South, North, South East Asian and Oceania the data showed that Primary Hepatocellular Carcinoma is common in most areas, but has a lower incidence amongst the non useful method of diagnosis. New biochemical and immunological markers are being studied. Untreated disease seldom survived more than 3 months. Various treatment protocols are being done since about 85% of tumours are non resectible at presentation. A population screening is done in China and on a risk groups in Taiwan and Singapore.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252810

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

Review 1.  Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

Authors:  C J Oon; M A Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 2.  Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.

Authors:  Miny Samuel; Pierce K-H Chow; Edwin Chan Shih-Yen; David Machin; Khee-Chee Soo
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.